(FHLC) Fidelity MSCI Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3160926008 • Health
FHLC: Pharmaceuticals, Biotechnology, Medical Devices, Health Care Services
The Fidelity® MSCI Health Care Index ETF (FHLC) is designed to track the performance of the MSCI USA IMI Health Care 25/50 Index, which represents the U.S. healthcare sector. The fund invests at least 80% of its assets in securities from its underlying index, which includes companies across various healthcare subsectors such as pharmaceuticals, biotechnology, and medical devices. While it may hold all the securities in the index, it is not required to do so. As a non-diversified fund, it can have a higher concentration in certain securities compared to diversified funds. With an AUM of $2.489 billion, FHLC is a substantial player in the healthcare ETF space.
From a technical standpoint, FHLC is currently trading at $65.05, slightly above its 20-day SMA of $64.46 but below its 50-day and 200-day SMAs of $67.08 and $69.01, respectively. This indicates short-term momentum is weakening compared to its medium-term trend. The ATR of 1.50 reflects moderate volatility. Over the next three months, if the 20-day SMA continues to fall below the 50-day SMA, it may signal further downside. However, the healthcare sectors defensive characteristics and the funds alignment with long-term demographic trends could provide support.
Additional Sources for FHLC ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FHLC ETF Overview
Market Cap in USD | 2,489m |
Category | Health |
TER | 0.08% |
IPO / Inception | 2013-10-21 |
FHLC ETF Ratings
Growth Rating | 43.2 |
Fundamental | - |
Dividend Rating | 49.5 |
Rel. Strength | -8.71 |
Analysts | - |
Fair Price Momentum | 60.51 USD |
Fair Price DCF | - |
FHLC Dividends
Dividend Yield 12m | 1.49% |
Yield on Cost 5y | 2.25% |
Annual Growth 5y | 3.37% |
Payout Consistency | 86.0% |
FHLC Growth Ratios
Growth Correlation 3m | -83.5% |
Growth Correlation 12m | -16.3% |
Growth Correlation 5y | 80.3% |
CAGR 5y | 8.06% |
CAGR/Max DD 5y | 0.45 |
Sharpe Ratio 12m | 0.21 |
Alpha | -6.88 |
Beta | 0.538 |
Volatility | 26.41% |
Current Volume | 150.5k |
Average Volume 20d | 135.2k |
As of April 30, 2025, the stock is trading at USD 65.47 with a total of 150,456 shares traded.
Over the past week, the price has changed by +3.58%, over one month by -4.17%, over three months by -5.17% and over the past year by +0.47%.
Partly, yes. Based on ValueRay Analyses, Fidelity MSCI Health Care (NYSE ARCA:FHLC) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.17 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FHLC as of April 2025 is 60.51. This means that FHLC is currently overvalued and has a potential downside of -7.58%.
Fidelity MSCI Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, FHLC Fidelity MSCI Health Care will be worth about 66.8 in April 2026. The stock is currently trading at 65.47. This means that the stock has a potential upside of +1.99%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 66.8 | 2% |